Literature DB >> 15288885

Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men.

Shunsaku Mizushima1, Kenji Ohshige, Junko Watanabe, Maki Kimura, Takashi Kadowaki, Yasunori Nakamura, Osamu Tochikubo, Hirotsugu Ueshima.   

Abstract

BACKGROUND: A double-blind randomized controlled trial was carried out to assess the effect of sour milk, containing two tripeptides (valine-proline-proline and isoleucine-proline-proline), on blood pressure (BP).
METHODS: A total of 46 borderline hypertensive men aged 23 to 59 years were recruited at their workplace for this trial. Subjects were randomly allocated into two groups; sour milk drink group (S-group, n = 23) and placebo (acidified milk) drink group (P-group, n = 23) for 4 weeks. Blood pressure was measured twice at each occasion by a physician, at the health center of the company, with a mercury at baseline, 2 and 4 weeks. Statistical analysis was performed by SPSS 10.0J.
RESULTS: The S-group and P-group showed no significant difference in baseline systolic BP (mean [SD], S: 147.6 [9.6], P: 145.3 [13.0]) or diastolic BP (S: 95.3 [9.9], P: 91.5 [9.6]). In the S-group, change in systolic BP at 2 and 4 weeks were -4.3 mm Hg (95% confidence interval [CI] -8.3 to -0.4; P = .032) and -5.2 mm Hg (95% CI -10.1 to -0.3; P = .039), both statistically significant. Diastolic BP showed change from -1.7 mm Hg (95% CI -5.4 to 2.0) at 2 weeks and -2.0 (95% CI -5.4 to 1.5) at 4 weeks, respectively. In the P-group, change in systolic BP were -0.5 (95% CI -5.8 to 4.8) at 2 weeks and -3.7 (95% CI -8.3 to 0.9) and change in diastolic BP were -0.6 (95% CI -4.7 to 3.6) and -0.3 (95% CI -3.9 to 3.3), which were not statistically significant.
CONCLUSIONS: This trial demonstrated the beneficial effect of sour milk on BP in borderline hypertensive men who were not taking antihypertensive medication. Copyright 2004 American Journal of Hypertension, Ltd.

Entities:  

Mesh:

Year:  2004        PMID: 15288885     DOI: 10.1016/j.amjhyper.2004.03.674

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  21 in total

Review 1.  Bioactive peptides of animal origin: a review.

Authors:  Z F Bhat; Sunil Kumar; Hina Fayaz Bhat
Journal:  J Food Sci Technol       Date:  2015-01-21       Impact factor: 2.701

Review 2.  Current Perspectives on Antihypertensive Probiotics.

Authors:  Eric Banan-Mwine Daliri; Byong H Lee; Deog H Oh
Journal:  Probiotics Antimicrob Proteins       Date:  2017-06       Impact factor: 4.609

3.  Comparison of Bayesian Sample Size Criteria: ACC, ALC, and WOC.

Authors:  Jing Cao; J Jack Lee; Susan Alber
Journal:  J Stat Plan Inference       Date:  2009-12-01       Impact factor: 1.111

4.  Milk Products Containing Bioactive Tripeptides Have an Antihypertensive Effect in Double Transgenic Rats (dTGR) Harbouring Human Renin and Human Angiotensinogen Genes.

Authors:  Tiina Jauhiainen; Taru Pilvi; Zhong Jian Cheng; Hannu Kautiainen; Dominik N Müller; Heikki Vapaatalo; Riitta Korpela; Eero Mervaala
Journal:  J Nutr Metab       Date:  2009-11-30

Review 5.  Beneficial health effects of milk and fermented dairy products--review.

Authors:  L Ebringer; M Ferencík; J Krajcovic
Journal:  Folia Microbiol (Praha)       Date:  2008-12-16       Impact factor: 2.099

6.  Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials.

Authors:  Are Hugo Pripp
Journal:  Food Nutr Res       Date:  2008-01-18       Impact factor: 3.894

Review 7.  Casein-derived lactotripeptides reduce systolic and diastolic blood pressure in a meta-analysis of randomised clinical trials.

Authors:  Ágnes A Fekete; D Ian Givens; Julie A Lovegrove
Journal:  Nutrients       Date:  2015-01-20       Impact factor: 5.717

Review 8.  Molecular targets of antihypertensive peptides: understanding the mechanisms of action based on the pathophysiology of hypertension.

Authors:  Kaustav Majumder; Jianping Wu
Journal:  Int J Mol Sci       Date:  2014-12-24       Impact factor: 5.923

Review 9.  The improvement of hypertension by probiotics: effects on cholesterol, diabetes, renin, and phytoestrogens.

Authors:  Huey-Shi Lye; Chiu-Yin Kuan; Joo-Ann Ewe; Wai-Yee Fung; Min-Tze Liong
Journal:  Int J Mol Sci       Date:  2009-08-27       Impact factor: 6.208

10.  VPPIPP and IPPVPP: two hexapeptides innovated to exert antihypertensive activity.

Authors:  Fengyun Ding; Bingjun Qian; Xin Zhao; Shanqi Shen; Yun Deng; Danfeng Wang; Feng Zhang; Zhongquan Sui; Pu Jing
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.